Soleno Therapeutics announced the awarding of a patent for diazoxide choline controlled-release (DCCR) tablets, the company’s investigational therapy for Prader-Willi…
Articles by Diogo Pinto
Soleno Therapeutics recently received fast track status from the U.S. Food and Drug Administration for diazoxide choline controlled-release (DCCR),…
Sleeping children with Prader-Willi syndrome (PWS) and severe obstruction of the upper airways — those between the nose and the…
People with Prader-Willi syndrome (PWS) may have an increased risk for coronary artery disease (CAD), a Portuguese case study suggests.
A 24-week exercise program showed encouraging results in controlling obesity and diabetes in a young man with Prader-Willi syndrome,…
The prevalence of gastro-esophageal reflux disease (GORD), a condition also known as GERD, was found to be high among patients…
Low serotonin levels in the brain are responsible for a greater prevalence of affective psychosis in patients with a type of…
Silent aspiration, a consequence of a swallowing dysfunction, was detected in infants with Prader-Willi syndrome (PWS) by fluorescent live…
In France, infants with Prader-Willi syndrome (PWS) are being diagnosed and receiving care soon after birth. But improvements are still…